Quantitative scale of oral mucositis associated with autologous bone marrow transplantation

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 6, 1996, Pages 381-387

  Tardieu, C ^a   Cowen, D ^b   Thirion, X ^a   Franquin, J C ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

Autologous bone marrow transplantation; Oral mucotitis; Quantitative scale

Indexed keywords

CYCLOPHOSPHAMIDE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; MOUTH MUCOSA; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STOMATITIS;

EID: 0030293420     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-1955(96)00026-7     Document Type: Article

References (29)

1. 1. Dreizen S. Description and incidence of oral complications. NCI Monogr 1990, 9, 11-15.
2. 2. Sonis S, Clark J. Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology 1991, 12, 92-95.
3. 3. Raber-Durlacher JE, Abraham L, Van Leeuwen EF, Lustig KH, Van Winkelhof AJ. The prevention of oral complications in bone marrow transplantations by means of oral hygiene and dental intervention. Neth J Med 1989, 34, 98-108.
4. 4. Schubert MM, Bronwen EW, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Cancer 1992, 69(10), 2469-2477.
5. 5. Schubert MM, Newton RE. The use of benzydamine for the management of cancer therapy-induced mucositis: preliminary report of a multicentric study. Int J Tiss Reac 1987, 9, 99-103.
6. 6. Kolbinson DA, Schubert MM, Flournoy N, Truelove EL. Early oral changes following bone marrow transplantation. Oral Surg Oral Med 1988, 66, 130-138.
7. 7. Raemaekers J, De Witte T, Schattenberg A, Van Der Lely N. Prevention of leukaemic relapse after transplantation with lymphocyte-depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines. Bone Marrow Transplant 1989, 4, 167-171.
8. 8. Epstein JB. Infection prevention in bone marrow transplantation and radiation patients. NCI Monograph 1990, 9, 73-85.
9. 9. Weisdorf DJ, Bostrom B, Racther D, et al. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplantation 1989, 4, 89-95.
10. 10. Herrmann F, Schulz G, Weiser M, et al. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. Hematol Blood Transfusion 1990, 33, 717-723.
11. 11. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann TM. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991, 9, 449-452.
12. 12. Liesche G, Ramenghi U, O'Connor M, Sheridan W, Szer J, Morstyn G. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. Br J Haematol 1992, 82, 589-595.
13. 13. For the French group for the treatment of adult ALL (FGTAL). Treatment of 225 adults with acute lymphoblastic leukemia (ALL) initial results. Acute leukemia: prognosis factors and treatment strategies. Int Symp, Münster, Germany, 1986 (abstract 21).
14. 14. Vey N, Blaise D, Stoppa AM, et al. Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission. Bone Marrow Transplantation 1994, 14, 383-388.
15. 15. Seto BG, Kim M, Wolinsky L, Mito RS, Champlin R. Oral mucositis in patients undergoing bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1985, 60, 493-497.
16. 16. Park JP, Park NH. Effect of chlorhexidine on the in vitro and in vivo herpes simplex virus infection. Oral Surg Oral Med Oral Pathol 1989, 67, 149-153.
17. 17. Bernstein IH, Garbin CP, Teng GK. Applied Multivariate Analysis. New York, Springer, Chapter 12, 1988.
18. 18. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16, 297-334.
19. 19. Guttman L. A basis for analysing test-retest reliability. Psychometrika 1945, 10, 255-282.
20. 20. WHO. Handbook for reporting results of cancer treatment. World Health Organization: Geneva, 1977, 48, 195-210.
21. 21. Shenep JL, Kalwinsky DK, Hutson PR, et al. Efficacy of oral sulfacrate suspension in prevention and treatment of chemotherapy-induced mucositis. J Pediatr 1988, 113, 758-763.
22. 22. Beck S. Impact of a systematic oral care protocol on stomatitis after chemotherapy. Cancer Nurs 1988, 2(3), 185-199.
23. 23. Eilers J, Berger AM, Petersen MC. Development, testing and application of the oral assessment guide. Oncol Nurs Forum 1988, 15, 325-330.
24. 24. Walsh LJ, Hill G, Seymour G, Roberts A. A scoring system for the quantitative evaluation of oral mucositis during bone marrow transplantation. Spec Care Dent 1990, 190-195.
25. 25. WCCNR. Development of a staging system for chemotherapy-induced stomatitis in Western Consortium for Cancer Nursing Research. Cancer Nurs 1991, 14, 6-12.
26. 26. Spijkervet FKL, Van Saene HKF, Panders AK, Vermey A, Mehta DM. Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol 1989, 18, 167-171.
27. 27. Schubert MM. Measurement of oral tissue damage and mucositis pain. In CR Chapman, KH Foley, Eds. Current and Emerging Issues in Cancer Pain: Research and Practice. New York, Raven Press, 1993, Chapter 15, 247-265.
28. 28. Donnelly JP, Muus P, Schattenberg A, De Witte T, Horrevorts A, De Pauw BE. A scheme for daily monitoring of oral mucositis in allogenic BMT recipients. Bone Marrow Transplantation 1992, 9, 409-413.
29. 29. Chapko MK, Syrjala KL, Schilter L, Cummings C, Sullivan KM. Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea. Bone Marrow Transplant 1989, 4, 181-186.